Oncology & Cancer

Response-guided neoadjuvant chemo beneficial in breast CA

(HealthDay)—For patients with early breast cancer, a response-guided neoadjuvant chemotherapy approach seems beneficial, according to a study published online Sept. 3 in the Journal of Clinical Oncology.